Effect of napabucasin and doxorubicin via the Jak2/Stat3 signaling pathway in suppressing the proliferation of neuroblastoma cells

Purpose: Napabucasin (NP) is a natural compound that can suppress Cancer cell proliferation and cell cycle by inhibition of the signal transducer and activator of transcription 3 (STAT3) gene. We examined the effects of NP on the proliferation and invasion of neuroblastoma cells (SH-SY5Y).

Methods: Human neuroblastoma SH-SY5Y cell line was used in this study. NP was administered to groups at the doses of 0.3-1 µM. Cell viability was analyzed by MTT assay. Real-time quantitative reverse transcription polymerase chain reaction and western blot analysis assessed the expressions of interleukin (IL)-6 dependent JAK2/STAT3 signaling pathway. The MTT cell viability method was applied to determine the antagonistic-synergistic effects and inhibitory concentration (IC50) doses of doxorubicin (DX) and NP.

Results: It was determined that 0.3-1 µM doses of NP killed the cells almost completely after 48 hours, and also that JAK2/STAT3 expressions decreased dose-dependently via IL-6. At the protein level, NP and DX were found to reduce JAK2 and STAT3 levels.

Conclusions: NP showed that it suppresses the proliferation of neuroblastoma cells. Due to its inhibitory effect on JAK2 and STAT3, it can be used to prevent invasion of SH-SY5Y cells. NP, which can inactivate JAK2/STAT3, can be used as a treatment agent by combining with DX in proliferation pathway in neuroblastoma.